冠心病患者CRP与LDL-C检测的临床价值
摘要
本文分析了冠心病（CHD）患者中c反应蛋白（CRP）和低密度脂蛋白胆固醇（LDL-C）的水平，旨在探讨联检CRP和LDL-C在CHD患者中的临床价值。
出处
《放射免疫学杂志》
CAS
2013年第1期121-122,共2页
Journal of Radioimmanology
参考文献4
-
1唐古生,沈茜.急性冠状动脉综合征的早期诊断指标[J].中华检验医学杂志,2011,34(1):88-92. 被引量：6
-
2Ridker PM, Cushman M, Stampfer M J, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [ J ]. N Engl J Med, 1997,336:973-979.
-
3Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation,predicts future risk of coronary heart disease in in- itially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) augsburg cohort study, 1984-1992 [ J ]. Circulation, 1999,99:237-242.
-
4金亚平,秦光明,张松照.血清高敏C-反应蛋白在心血管病变中的表达特性[J].中华检验医学杂志,2002,25(6):357-359. 被引量：108
二级参考文献30
-
1McCullough PA,Peacock WF,O' Neil B,et al.Capturing the pathophysiology of acute coronary syndromes with circulating biomarkers.Rev Cardiovasc Med,2010,11 Suppl 2:S3-12.
-
2Zakynthinos E,Pappa N.Inflammatory biomarkers in coronary artery disease.J Cardiol,2009,53:317-333.
-
3Inoue T,Kato T,Uchida T,et al.Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting.J Am Coll Cardiol,2005,46:239-245.
-
4Pearson TA,Mensah GA,Hong Y,et al.CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease:Application to Clinicsl and Public Health Practice:overview.Circulation,2004,110:e543-544.
-
5Fouad HH,A1-Dera H,Bakhoum SW,et al.Levels of sCD40 ligand in chronic and acute coronary syndromes and its relation to angiographic extent of coronary arterial narrowing.Angiology.2010,61:567-573.
-
6Morrow DA,Sabatine MS,Brennan ML,et al.Concurrent evaluation of novel cardiac biornarkers in acute coronary syndrome:myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.Eur Heart J,2008,29:1096-1102.
-
7Brennan ML,Penn MS,Van Lente F,et al.Prognostic value of myeloperoxidase in patients with chest pain.N Engl J Med,2003,349:1595-1604.
-
8Schindhelm RK,van der Zwan LP,Teerlink T,et al.Myeloperoxidase:a useful biomarker for cardiovascular disease risk stratification? Clin Chem,2009,55:1462-1470.
-
9Hochholzer W,Morrow DA,Giugliano RP.Novel biomarkers in cardiovascular disease:update 2010.Am Heart J,2010,160:583-594.
-
10Ndrepepa G,Braun S,Mehilli J,et al.Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.Eur J Clin Invest,2008,38:90-96.
共引文献112
-
1唐永平.超敏C-反应蛋白(HS-CRP)在预测心血管疾病危险性中的意义[J].中外医疗,2007,26(18). 被引量：6
-
2蒋火刚,蒋菊花,刘凤.C反应蛋白和红细胞沉降率测定在3种疾病中的应用评价[J].检验医学与临床,2006,3(7). 被引量：1
-
3陈琳.高血压冠心病患者的血清C反应蛋白变化分析[J].哈尔滨医药,2008,28(5).
-
4袁劲松,盛裕芬.血清超敏C反应蛋白检测与冠心病[J].医学检验与临床,2003,15(5):21-22. 被引量：1
-
5申向民,杨期东,张永利,唐震宇,黄晓松,奉俊敏.脑梗死患者颈动脉斑块及其与高敏C反应蛋白的关系[J].实用医学杂志,2006,22(21):2489-2491. 被引量：6
-
6康红,刘小玲.预测心血管危险指数的相关标志物评估[J].重庆医学,2004,33(8):1179-1181. 被引量：3
-
7郑文亮.CRP与FIB在急性冠状动脉综合征中的预测价值[J].临床医学,2004,24(8):4-5.
-
8金幸,尤昕,魏学峰,李玉花.比浊免疫法测定血清C-反应蛋白的评价[J].吉林医学,2004,25(10):12-13. 被引量：4
-
9叶雄伟,于小妹,王强,毕其华.急性心梗患者血清超敏C-反应蛋白与心梗指标的相关性分析[J].心脑血管病防治,2005,5(1):13-15. 被引量：14
-
10谷秀娟,王璐,惠玉芬.血清Hs-CRP在心脑血管疾病中的临床应用探讨[J].陕西医学杂志,2005,34(4):466-467. 被引量：7
-
1朱海云.血脂与糖化血红蛋白联检在糖尿病诊断及治疗中的意义[J].吉林医学,2012,33(21):4503-4503. 被引量：2
-
2成红霞,李斌.肝病纤维化指标和AFP联检的意义[J].放射免疫学杂志,2007,20(6):552-553.
-
3邬林枫,曾劲峰,孙元璋,龙洁萍,王立林.化学发光微粒子免疫测定技术对低风险人群HCV感染确证的应用价值[J].国际检验医学杂志,2017,38(10):1301-1303. 被引量：2
